CLDN4 and metastatic carcinoma: We experienced an excellent value of the “two-hits” panel of Claudin-4 and BAP1 in the differential diagnosis between mesothelioma with epithelioid features and conventional metastatic carcinomas, demonstrating a 94% sensitivity, a 100% specificity and a 96% diagnostic accuracy [3].